These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 19277723)

  • 21. Hepatic portal venous gas: a rare complication of malignant bowel obstruction during the administration of octreotide.
    Maeda I; Tsuneto S; Yasui Y; Ueda Y; Kimura T
    J Pain Symptom Manage; 2014 Feb; 47(2):e2-5. PubMed ID: 24388125
    [No Abstract]   [Full Text] [Related]  

  • 22. Can malignant bowel obstruction in advanced cancer patients be treated at home?
    Porzio G; Aielli F; Verna L; Galletti B; Shoja E Razavi G; Ficorella C
    Support Care Cancer; 2011 Mar; 19(3):431-3. PubMed ID: 20872024
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of octreotide and hyoscine butylbromide in controlling gastrointestinal symptoms due to malignant inoperable bowel obstruction.
    Mercadante S; Ripamonti C; Casuccio A; Zecca E; Groff L
    Support Care Cancer; 2000 May; 8(3):188-91. PubMed ID: 10789958
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Randomized clinical trial comparing octreotide and scopolamine butylbromide in symptom control of patients with inoperable bowel obstruction due to advanced ovarian cancer.
    Peng X; Wang P; Li S; Zhang G; Hu S
    World J Surg Oncol; 2015 Feb; 13():50. PubMed ID: 25889313
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Clinical efficacy of octreotide acetate in cancer patients with malignant bowel symptoms depend on terminal stage].
    Uchino R; Kusano S; Hanada N; Ohara C; Okino T; Yamaguchi K
    Gan To Kagaku Ryoho; 2011 Feb; 38(2):255-7. PubMed ID: 21368489
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The role of octreotide in malignant bowel obstruction.
    Krammer LM
    Oncol Nurs Forum; 1999 Jun; 26(5):831-2. PubMed ID: 10382174
    [No Abstract]   [Full Text] [Related]  

  • 27. [Pharmacological treatment of malignant bowel obstruction in severely ill and dying patients : a systematic literature review].
    Klein C; Stiel S; Bükki J; Ostgathe C
    Schmerz; 2012 Sep; 26(5):587-99. PubMed ID: 23052994
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Sustained release octreotide may have a role in the treatment of malignant bowel obstruction.
    Massacesi C; Galeazzi G
    Palliat Med; 2006 Oct; 20(7):715-6. PubMed ID: 17060271
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Health-related quality of life in patients with inoperable malignant bowel obstruction: secondary outcome from a double-blind, parallel, placebo-controlled randomised trial of octreotide.
    McCaffrey N; Asser T; Fazekas B; Muircroft W; Agar M; Clark K; Eckermann S; Lee J; Joshi R; Allcroft P; Sheehan C; Currow DC
    BMC Cancer; 2020 Oct; 20(1):1050. PubMed ID: 33129304
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Octreotide prevents the pathological alterations of bowel obstruction in cancer patients.
    Mercadante S; Avola G; Maddaloni S; Salamone G; Aragona F; Rodolico V
    Support Care Cancer; 1996 Sep; 4(5):393-4. PubMed ID: 8883235
    [No Abstract]   [Full Text] [Related]  

  • 31. Double-blind, placebo-controlled, randomized trial of octreotide in malignant bowel obstruction.
    Currow DC; Quinn S; Agar M; Fazekas B; Hardy J; McCaffrey N; Eckermann S; Abernethy AP; Clark K
    J Pain Symptom Manage; 2015 May; 49(5):814-21. PubMed ID: 25462210
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Octreotide may prevent definitive intestinal obstruction.
    Mercadante S; Kargar J; Nicolosi G
    J Pain Symptom Manage; 1997 Jun; 13(6):352-5. PubMed ID: 9204656
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Palliative Management of Inoperable Malignant Bowel Obstruction: Prospective, Open Label, Phase 2 Study at an NCI Comprehensive Cancer Center.
    Walter M; Hansen E; Hamid S; Carozza D; Mann G; Roche C; George A; Attwood K; Case A
    J Pain Symptom Manage; 2024 Jan; 67(1):20-26. PubMed ID: 37769820
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Gastric adenocarcinoma presenting with intestinal pseudoobstruction, successfully treated with octreotide.
    Sharma S; Ghoshal UC; Bhat G; Choudhuri G
    Indian J Med Sci; 2006 Nov; 60(11):467-70. PubMed ID: 17090868
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Malignant irreversible intestinal obstruction: the powerful association of octreotide to corticosteroids, antiemetics, and analgesics.
    Weber C; Zulian GB
    Am J Hosp Palliat Care; 2009; 26(2):84-8. PubMed ID: 19088264
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pathophysiology and palliation of inoperable bowel obstruction in patients with ovarian cancer.
    Jatoi A; Podratz KC; Gill P; Hartmann LC
    J Support Oncol; 2004; 2(4):323-34; discussion 334-7. PubMed ID: 15357517
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Octreotide in relieving gastrointestinal symptoms due to bowel obstruction.
    Mercadante S; Spoldi E; Caraceni A; Maddaloni S; Simonetti MT
    Palliat Med; 1993; 7(4):295-9. PubMed ID: 7505187
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Scopolamine butylbromide plus octreotide in unresponsive bowel obstruction.
    Mercadante S
    J Pain Symptom Manage; 1998 Nov; 16(5):278-80. PubMed ID: 9846021
    [No Abstract]   [Full Text] [Related]  

  • 39. Clinician-reported changes in octreotide prescribing for malignant bowel obstruction as a result of an adequately powered phase III study: A transnational, online survey.
    Campbell R; McCaffrey N; Brown L; Agar MR; Clark K; Currow DC
    Palliat Med; 2018 Sep; 32(8):1363-1368. PubMed ID: 29856291
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Palliative Medical Management of Inoperable Malignant Bowel Obstruction With "Triple Therapy": Dexamethasone, Octreotide, and Metoclopramide.
    Wey W; Mian M; Calabrese R; Hansen E; Walter M; Wang C; Miller A; Case AA
    Am J Hosp Palliat Care; 2021 Apr; 38(4):340-345. PubMed ID: 33084354
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.